These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38003)

  • 41. Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring.
    Branfman AR; Bruni RJ; Merrill YN; Chadwick M; Strong JM; Ervin TJ
    J Chromatogr; 1980 May; 182(2):163-9. PubMed ID: 7380909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo pyrimidine nucleotide synthesis in the preimplantation mouse embryo.
    Troike DE; Brinster RL
    Exp Cell Res; 1981 Aug; 134(2):481-4. PubMed ID: 7274344
    [No Abstract]   [Full Text] [Related]  

  • 43. Determinants of L-aspartate and IMP recognition in Escherichia coli adenylosuccinate synthetase.
    Gorrell A; Wang W; Underbakke E; Hou Z; Honzatko RB; Fromm HJ
    J Biol Chem; 2002 Mar; 277(11):8817-21. PubMed ID: 11781326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphonacetyl-L-aspartate: an aspartate transcarbamylase inhibitor causing larval death and rudimentary wing phenocopies in Drosophila melanogaster.
    Holaday BJ; Fristrom JW
    Experientia; 1977 Apr; 33(4):428-30. PubMed ID: 405235
    [No Abstract]   [Full Text] [Related]  

  • 45. Determinants of the toxicity of L-alanosine to various organs of the mouse.
    Tyagi AK; Thake DC; McGee E; Cooney DA
    Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and use of potent, specific enzyme inhibitors.
    Stark GR; Bartlett PA
    Pharmacol Ther; 1983; 23(1):45-78. PubMed ID: 6361807
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanism of the effect of serine and threonine on ammoniagenesis and biosynthesis of orotate in the mouse].
    Nelson J; Qureshi IA; Vasudevan S
    Clin Invest Med; 1992 Apr; 15(2):113-21. PubMed ID: 1591893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new assay for L-asparagine synthetase.
    Luehr CA; Schuster SM
    J Biochem Biophys Methods; 1980 Sep; 3(3):151-61. PubMed ID: 6108975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; King WM; Cragoe EJ
    Biochem Pharmacol; 1975 Oct; 24(19):1787-92. PubMed ID: 9943
    [No Abstract]   [Full Text] [Related]  

  • 50. Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulfonamide and sulfonylhydrazide analogues of L-asparagine.
    Brynes S; Burckart GJ; Mokotoff M
    J Med Chem; 1978 Jan; 21(1):45-9. PubMed ID: 22754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A conserved glutamate controls the commitment to acyl-adenylate formation in asparagine synthetase.
    Meyer ME; Gutierrez JA; Raushel FM; Richards NG
    Biochemistry; 2010 Nov; 49(43):9391-401. PubMed ID: 20853825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential inhibitors of L-asparagine biosynthesis. 3. Aromatic sulfonyl fluoride analogs of L-asparagine and L-glutamine.
    Mokotoff M; Brynes S; Bagaglio JF
    J Med Chem; 1975 Sep; 18(9):888-91. PubMed ID: 240024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
    Nord LD; Stolfi RL; Colofiore JR; Martin DS
    Biochem Pharmacol; 1996 Mar; 51(5):621-7. PubMed ID: 8615898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo.
    Johnson RK
    Biochem Pharmacol; 1977 Jan; 26(1):81-4. PubMed ID: 831730
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of nucleic acid inhibitors on the development of Angiostrongylus costaricensis in vitro.
    Hata H; Niimura M; Yano A
    J Vet Med Sci; 1998 Oct; 60(10):1153-5. PubMed ID: 9819773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of L-asparagine synthetase by mucochloric and mucobromic acids.
    Cooney DA; Milman HA; Jayaram HN; Homan ER
    Enzyme; 1976; 21(6):524-39. PubMed ID: 12938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential antitumor agents via inhibitors of L-asparagine synthetase: substituted sulfonamides and sulfonyl hydrazides related to glutamine.
    Brynes S; Fiorina VJ; Cooney DA; Milman HA
    J Pharm Sci; 1978 Nov; 67(11):1550-3. PubMed ID: 30838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New peptide derivatives of L-asparagic acid with conserving action.
    Năstase V; Sunel V; Budeanu C; Rusan M; Dragomir B
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(3):463-7. PubMed ID: 594531
    [No Abstract]   [Full Text] [Related]  

  • 59. Potential inhibitors of L-asparagine biosynthesis. 2. Chemistry and biological activity of beta-hydroxyaspartic acid and its derivatives.
    Mokotoff M; Bagaglio JF; Parikh BS
    J Med Chem; 1975 Apr; 18(4):354-8. PubMed ID: 164550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro biological evaluation of N-[(5-amino-1-beta-D-ribofuranosyl-1H-imidazol-4-yl)carbonyl]-3- (hydroxynitrosamino)-L-alanine (L-alanosine AICO ribonucleoside).
    Strazzolini P; Malabarba A; Ferrari P; Grandi M; Cavalleri B
    J Med Chem; 1984 Oct; 27(10):1295-9. PubMed ID: 6592359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.